🚀 Exciting Announcement!
February 25, 2025
Ash Alavijeh,
Pharmidex's Head of Operations, will be attending OBN BioTuesday: "A Spotlight on the Latest R&D in the Metabolic Disease and Obesity Space" hosted by FTI Consulting in London.
Ash is eager to connect, share insights, and explore new collaborations that advance drug discovery and improve outcomes in metabolic disease and obesity research. Looking forward to meeting you there!
#OBNBioTuesday #Pharmidex #DrugDiscovery #MetabolicDisease #ObesityResearch
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
